结合人工智能与流式细胞术实现浆细胞病的准确分类
研究基于两个独立队列共348例患者,采用多参数流式细胞术分析浆细胞表型,发现CD27和CD38在意义未明单克隆丙种球蛋白病(MGUS)与多发性骨髓瘤(MM)间差异表达(P < 0·001),并构建梯度提升机模型及决策算法,在疑似浆细胞病中实现≥95%的预测分类且MGUS与冒烟型多发性骨髓瘤(SMM)间无误判,算法在独立验证队列中验证并在线公开。
要点
- CD27和CD38在MGUS与MM间差异表达(P < 0·001)。
- 异常浆细胞百分比和浆细胞/CD117阳性前体比是区分MGUS与MM最有影响的参数。
- 决策算法在疑似浆细胞病中预测分类≥95%,MGUS与SMM间无误判。
核心结论
- 结合人工智能与多参数流式细胞术可准确分类浆细胞病,所建模型在线公开供全球流式中心使用。
研究设计与样本
- 研究基于两个独立队列共348例患者,发现队列包括123例MM和97例MGUS,验证队列包括87例MM和41例MGUS。
主要发现
- CD27和CD38在MGUS与MM间差异表达(P < 0·001)。
- 梯度提升机方法显示异常浆细胞百分比和浆细胞/CD117阳性前体比是诊断时区分MGUS与MM最有影响的参数。
- 决策算法在疑似浆细胞病中实现≥95%的预测分类,且MGUS与SMM间无误判。
- 算法在独立浆细胞病队列(87例MM、41例MGUS)中验证。
临床怎么用
- 人工智能模型已作为诊断工具应用网站免费在线公开(https://aihematology.shinyapps.io/PCdyscrasiasToolDg/),供全球所有多参数流式细胞术中心使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monoclonal gammopathy of unknown significance (MGUS), smouldering multiple myeloma (SMM), and multiple myeloma (MM) are very common neoplasms. However, it is often difficult to distinguish between these entities. In the present study, we aimed to classify the most powerful markers that could improve diagnosis by multiparametric flow cytometry (MFC). The present study included 348 patients based on two independent cohorts. We first assessed how representative the data were in the discovery cohort (123 MM, 97 MGUS) and then analysed their respective plasma cell (PC) phenotype in order to obtain a set of correlations with a hypersphere visualisation. Cluster of differentiation (CD)27 and CD38 were differentially expressed in MGUS and MM (P < 0·001). We found by a gradient boosting machine method that the percentage of abnormal PCs and the ratio PC/CD117 positive precursors were the most influential parameters at diagnosis to distinguish MGUS and MM. Finally, we designed a decisional algorithm allowing a predictive classification ≥95% when PC dyscrasias were suspected, without any misclassification between MGUS and SMM. We validated this algorithm in an independent cohort of PC dyscrasias (n = 87 MM, n = 41 MGUS). This artificial intelligence model is freely available online as a diagnostic tool application website for all MFC centers worldwide (https://aihematology.shinyapps.io/PCdyscrasiasToolDg/).
引用
- Clichet V, Harrivel V, Delette C, et al. Accurate classification of plasma cell dyscrasias is achieved by combining artificial intelligence and flow cytometry. Br J Haematol. 2021. PMID: 34730236. doi:10.1111/bjh.17933
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。